Tag: CBD
-
Xphyto (XPHY.C) just unlocked a pipeline of biosensor screening projects
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly.
-
![Xphyto (XPHY.C) advances delivery system for Parkinson’s drug]()
Xphyto (XPHY.C) advances delivery system for Parkinson’s drug
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies.
-
![Plus Products (PLUS.C): good deeds, good products, good numbers]()
Plus Products (PLUS.C): good deeds, good products, good numbers
“This will be the third year we have had the opportunity to partner with a local organization during pride month,” stated Mr. Heimark. “Last year we sold over 60,000 units and are looking forward to giving that record a run for its money this year.”
-
![HEXO (HEXO.T) surges 20% after it raises $57.5 million “to do stuff”.]()
HEXO (HEXO.T) surges 20% after it raises $57.5 million “to do stuff”.
To be blunt, Hexo is selling $15 pizzas with food-costs of $40. It’s not a great business model.
-
![The Inflection Point: It’s now or never for Plus Products (PLUS.C)]()
The Inflection Point: It’s now or never for Plus Products (PLUS.C)
When weed legalized in Canada, I wasn’t a consumer participant. Smoking up has never been my jam. I know some like the ritual of it all, but I see having to prep and grind and smoke as being similar to driving stick – I mean, why not also stop your car by cutting two holes…
-
The real reason for XPhyto’s (XPHY.C) freaky gravity-defying chart
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple partnerships with universities and research centers.
-
Aurora (ACB.NYSE) rolls back, Gaia Grow (GAIA.V) rolls on
“The simple fact of the matter is ACB is getting around a THIRD of their product returned in real dollar terms,” wrote Equity Guru’s Chris Parry two months ago, “That means they either REALLY suck at growing weed, or they really sucked at figuring out what the market was going to look like when planning…
-
![The Good, the Bad & the Ugly; Trulieve Cannabis (TRUL.C), KushCo Holdings (KSHB.OTC) and Hexo (HEXO.NYSE) release financials]()
The Good, the Bad & the Ugly; Trulieve Cannabis (TRUL.C), KushCo Holdings (KSHB.OTC) and Hexo (HEXO.NYSE) release financials
“Borrowing money and expanding hard in competition with MedMen (MMEN.C) is a two-edged sword,” explained Equity Guru’s Chris Parry, “In a strong market, you’re building far more value than you’re borrowing but, in a down market, you’re under extra pressure to keep things together when debts come due.”
-
![Nextleaf (OILS.C) cuts a deal with an Ontario cannabis grower]()
Nextleaf (OILS.C) cuts a deal with an Ontario cannabis grower
OIL’s CEO, Paul Pedersen, believes the key to a strong sustainable cannabis extraction business is innovative technology protected by international patents.
-
![1933 Industries (TGIF.C) scrambles to keep up with increased Nevada cannabis demand]()
1933 Industries (TGIF.C) scrambles to keep up with increased Nevada cannabis demand
Last week, Nevada Governor Steve Sisolak allowed the shops to continue at-home deliveries because marijuana is considered an “essential business”, reported The Reno Gazette, “Much like the grocery stores trying to fill orders for rice and potatoes, cannabis retailers cannot fill marijuana delivery orders fast enough.”
